Neurogene (NGNE) Capital Expenditures (2013 - 2026)
Neurogene's Capital Expenditures came in at $354,000 for Q2 2026, up 139.2% from $148,000 a year earlier and up 26.0% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Capital Expenditures (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Neurogene reported Capital Expenditures of $890,000, down 26.5% year-over-year; for FY2025, it came in at $1.18 million, up 46.4% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -11.8% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $808,000 in FY2024 (+151.7%), $321,000 in FY2023 (-85.6%), $2.23 million in FY2022 (-31.7%) and $3.26 million in FY2021 (+47.0%).
- The Q2 2026 figure represents the highest quarterly Capital Expenditures since Q1 2025.
- Year-over-year, Capital Expenditures increased in three of the last seven quarters, with growth averaging 12.6%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q2 2024 (growth of 461.0%), and the weakest in Q1 2023 (a decline of 93.6%).
- Business Quant data shows NGNE's Capital Expenditures at $281,000 (Q1 2026), $128,000 (Q4 2025) and $127,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Neurogene | 603.38 Mn | -399.62 Mn | - | 354,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 354,000.00 |
| Mar 31, 2026 | 281,000.00 |
| Dec 31, 2025 | 128,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 148,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Jun 30, 2024 | 460,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 128,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 82,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 322,000.00 |
| Jun 30, 2022 | 232,000.00 |
| Mar 31, 2022 | 452,000.00 |
| Dec 31, 2021 | 396,000.00 |
| Sep 30, 2021 | 587,000.00 |
API Access
Neurogene Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();